| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/10/2011 | US20110033896 Method for manufacturing an aqueous glucose solution from plants of the triticeae species |
| 02/10/2011 | US20110033894 Engineering surface epitopes to improve protein crystallization |
| 02/10/2011 | US20110033892 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
| 02/10/2011 | US20110033891 Mussel bioadhesive |
| 02/10/2011 | US20110033873 Proteinic marker for early diagnosis of liver cancer |
| 02/10/2011 | US20110033867 Use of biomarkers for detecting ovarian cancer |
| 02/10/2011 | US20110033839 Methods of Detecting Signatures of Disease or Conditions in Bodily Fluids |
| 02/10/2011 | US20110033838 Surface antigen protein mutant of hepatitis b virus surface antigen |
| 02/10/2011 | US20110033521 Molecules and Methods of Using Same for Treating MCP-1/CCR2 Associated Diseases |
| 02/10/2011 | US20110033518 Peptides promoting lipid efflux via abca1 and activating a lipoprotein lipase |
| 02/10/2011 | US20110033500 Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb-neisseria meningitidis |
| 02/10/2011 | US20110033492 Vaccines for brucellosis |
| 02/10/2011 | US20110033490 Compositions and methods for diagnosing and/or treating influenza infection |
| 02/10/2011 | US20110033489 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 02/10/2011 | US20110033487 Vaccines and diagnostics for the ehrlichioses |
| 02/10/2011 | US20110033481 Prospective identification and characterization of breast cancer stem cells |
| 02/10/2011 | US20110033478 Canine thymic stromal lymphopoietin protein and uses thereof |
| 02/10/2011 | US20110033472 Tumor Endothelial Marker 5-alpha Molecules and Uses Thereof |
| 02/10/2011 | US20110033470 Human G-Protein Coupled Receptor |
| 02/10/2011 | US20110033469 Leukotriene b4 binding soluble lipocalin receptor from ixodes ricinus |
| 02/10/2011 | US20110033467 Compositions and methods comprising a ligand of chemerinr |
| 02/10/2011 | US20110033442 Targets, including yap1, for antifungal drug discovery and therapy |
| 02/10/2011 | US20110033431 Type a2 botulinum toxin preparation |
| 02/10/2011 | US20110033424 Use of adenovirus and nucleic acids coding therefor |
| 02/10/2011 | US20110033384 Chimeric polypeptides and their use |
| 02/10/2011 | US20110033381 Molecular probe for imaging of pancreatic islet and the precursor, and use of the same |
| 02/10/2011 | DE10164805B4 Verfahren und Mittel zur Modifikation humaner Angiogenese Method and means for modification of human angiogenesis |
| 02/10/2011 | CA2770304A1 Anti-rsv immunogens and methods of immunization |
| 02/10/2011 | CA2770149A1 Controlled release formulations of lipocalin muteins |
| 02/10/2011 | CA2769748A1 Immunogenic composition comprising variants of staphylococcal clumping factor a |
| 02/10/2011 | CA2769326A1 Blood coagulation protein conjugates |
| 02/10/2011 | CA2769262A1 Methods and compositions for treating trinucleotide repeat disorders |
| 02/10/2011 | CA2769231A1 Porphyromonas gingivalis polypeptides |
| 02/10/2011 | CA2769001A1 Novel proteins |
| 02/10/2011 | CA2768990A1 Broad spectrum erbb ligand binding molecules and methods for preparing and using them |
| 02/10/2011 | CA2768748A1 Novel antipathogenic peptides |
| 02/10/2011 | CA2768428A1 Isolated polynucleotides and polypeptides, and methods of using same for increasing abiotic stress tolerance, yield, growth rate, vigor, biormass, oil content, and/or nitrogen useefficiency of plants |
| 02/09/2011 | EP2281897A2 Oncolytic mutant Herpes Simplex virus |
| 02/09/2011 | EP2281896A2 Transgenic plant-based methods for plant insect pests using RNAi |
| 02/09/2011 | EP2281895A2 Methods for enhancing stress tolerance in plants and compositions thereof |
| 02/09/2011 | EP2281894A2 Protein kinase stress-related proteins and methods of use in plants |
| 02/09/2011 | EP2281893A1 System for the expression of peptides on the bacterial surface |
| 02/09/2011 | EP2281891A2 Streptococcus antigens |
| 02/09/2011 | EP2281882A1 Nucleic acid containing chimeric gene derived from hepatitis type-c virus |
| 02/09/2011 | EP2281881A1 YEAST MUTANT AND SUBSTANCE PRODUCTION Method USING THE SAME |
| 02/09/2011 | EP2281878A1 Lipolytic enzyme |
| 02/09/2011 | EP2281843A1 Antibodies that immunospecifically bind to blys |
| 02/09/2011 | EP2281842A1 Antibodies that immunospecifically bind to BLyS |
| 02/09/2011 | EP2281836A1 Hybrid proteins from Parietaria judaica major allergens and uses thereof |
| 02/09/2011 | EP2281835A2 Anti-bacterial vaccine compositions |
| 02/09/2011 | EP2281834A2 Anti-bacterial vaccine compositions |
| 02/09/2011 | EP2281833A2 Anti-bacterial vaccine compositions |
| 02/09/2011 | EP2281832A2 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 02/09/2011 | EP2281831A2 Varicella Zoster virus vaccine |
| 02/09/2011 | EP2281830A2 Varicella Zoster virus vaccine |
| 02/09/2011 | EP2281829A2 PCV2 immunogenic compositions and methods of producing such compositions |
| 02/09/2011 | EP2281828A2 Compositions comprising modified erythropoietin |
| 02/09/2011 | EP2281576A1 Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition |
| 02/09/2011 | EP2281574A1 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same |
| 02/09/2011 | EP2281568A2 Uses of soluble CTLA4 mutant molecules |
| 02/09/2011 | EP2281198A2 Immunodominant mycobacterium tuberculosis peptides from cell wall proteins for early diagnosis and immunization |
| 02/09/2011 | EP2281047A1 Methods to produce rod-derived cone viability factor (rdcvf) |
| 02/09/2011 | EP2281045A1 Therapy delivery and monitoring using a gene of interest-reporter fusion protein and optical imaging |
| 02/09/2011 | EP2281039A2 Systems, methods and compositions for optical stimulation of target cells |
| 02/09/2011 | EP2281004A1 Prostate specific membrane antigen antibodies and antigen binding fragments |
| 02/09/2011 | EP2281001A1 Anti-areg/hb-egf antibodies and treatment |
| 02/09/2011 | EP2280996A2 AFFINITY MATURED CRIg VARIANTS |
| 02/09/2011 | EP2280995A2 Methods for treating inflammation |
| 02/09/2011 | EP2280994A1 Restoration of estrogen receptor-alpha activity |
| 02/09/2011 | EP2280993A1 Purification of peptides prepared by solid phase synthesis |
| 02/09/2011 | EP2280992A1 Polypeptides having alpha-amylase activity and polynucleotides encoding same |
| 02/09/2011 | EP2280991A2 Deletion mutants of flagellin and methods of use |
| 02/09/2011 | EP2280990A1 Nisin derivatives and the use thereof |
| 02/09/2011 | EP2280988A2 Angiogenic peptide |
| 02/09/2011 | EP2280727A1 Vaccine compositions for the treatment of dengue fever and uses thereof |
| 02/09/2011 | EP2280723A1 Zona pellucida binding peptides, expression vectors, compositions, and methods for species-specific immunocontraception of animals |
| 02/09/2011 | EP2280720A2 Collagen-binding synthetic peptidoglycans, preparation, and methods of use |
| 02/09/2011 | EP2085475B1 Method for production of cell strain capable of tetracycline-induced gene expression or cell strain having conditional gene knockout, and use of the cell strains |
| 02/09/2011 | EP1973942B1 Recombinant production of heparin binding proteins |
| 02/09/2011 | EP1970380B1 Inhibitor of the uracil-dna glycosylase enzyme and uses thereof |
| 02/09/2011 | EP1947111B1 Mucin glycoprotein and use thereof |
| 02/09/2011 | EP1885754B1 T cell receptors which specifically bind to vygfvracl-hla-a24 |
| 02/09/2011 | EP1877439B1 Il-21 variants |
| 02/09/2011 | EP1874808B1 Catalase gene and use thereof |
| 02/09/2011 | EP1725659B1 Natural igm antibodies and inhibitors thereof |
| 02/09/2011 | EP1716869B1 Drug for preventing or treating heart diseases comprising cd9 gene |
| 02/09/2011 | EP1648931B1 Multifunctional cytokines |
| 02/09/2011 | EP1585538B1 Non-hypertensive pegylated hemoglobins and methods of preparation thereof |
| 02/09/2011 | EP1577390B1 Human cancer-related genes, the products encoded thereby and applications thereof |
| 02/09/2011 | EP1573046B1 Protease resistant ti-growth hormone releasing hormone |
| 02/09/2011 | EP1545587B1 Lactoferrin compositions and methods of diabetic ulcer treatment |
| 02/09/2011 | EP1504098B2 A method for in vitro molecular evolution of protein function |
| 02/09/2011 | EP1311680B1 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor |
| 02/09/2011 | EP1280898B1 Modified es cells and es cell-specific gene |
| 02/09/2011 | EP1181313B1 Peptides for vaccinating against human cmv |
| 02/09/2011 | EP0986577B1 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 02/09/2011 | EP0848755B2 Vegf-related protein |
| 02/09/2011 | EP0771324B2 Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
| 02/09/2011 | EP0668777B2 Prostate-specific membrane antigen |
| 02/09/2011 | CN1969046B Peptide substrates recognisable by a botulinum toxin A, BoNT/A and the use thereof |